ArticleMolecular medicine reports2025

Dysregulation of the SREBP pathway is associated with poor prognosis and serves as a potential biomarker for the diagnosis of hepatocellular carcinoma.

Xiaodan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.